PATENT CLAIM ANALYSIS

Application Number: 15769095
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "183000"]

Abstract:
A method of treating a neurodegenerative disease is disclosed. The method comprises administering to the subject a therapeutically effective amount of a CXCR4 antagonist and lactate or/and zinc. Kits for treating same are also disclosed.

Claim (Index 12):
The method of  claim 1 , further comprising administering to the subject zinc.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 1.26667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12747302', '14006053', '15103234', '11650020', '14814988']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.780804842888661
- 35 USC 102 Novelty (BERT): 0.5283748585031992
- Combined Prediction Score: 0.7555618444501149
- Mean Citation Score: 281.543208
- Max Citation Score: 312.11142
- Similarity Product: 152.63499278593184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test